ZNG1C
gene geneOn this page
Also known as bA561O23.1
Summary
ZNG1C (Zn regulated GTPase metalloprotein activator 1C, HGNC:18519) is a protein-coding gene on chromosome 9q21.11, encoding Zinc-regulated GTPase metalloprotein activator 1C (Q5JTY5). Zinc chaperone that directly transfers zinc cofactor to target metalloproteins, thereby activating them.
Predicted to enable GTP binding activity; hydrolase activity; and metal ion binding activity. Predicted to be located in nucleus. Predicted to be active in cytoplasm.
Source: NCBI Gene 445571 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 38 total
- MANE Select transcript:
NM_201453
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18519 |
| Approved symbol | ZNG1C |
| Name | Zn regulated GTPase metalloprotein activator 1C |
| Location | 9q21.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bA561O23.1 |
| Ensembl gene | ENSG00000196873 |
| Ensembl biotype | protein_coding |
| OMIM | 611080 |
| Entrez | 445571 |
Gene structure
Transcript identifiers
Ensembl transcripts: 33 — 19 protein_coding, 8 nonsense_mediated_decay, 3 retained_intron, 3 protein_coding_CDS_not_defined
ENST00000360171, ENST00000377342, ENST00000377344, ENST00000377349, ENST00000469687, ENST00000478048, ENST00000611426, ENST00000612050, ENST00000614377, ENST00000614398, ENST00000615061, ENST00000616550, ENST00000618217, ENST00000618921, ENST00000619322, ENST00000621396, ENST00000621474, ENST00000622755, ENST00000622817, ENST00000890596, ENST00000890597, ENST00000890598, ENST00000890599, ENST00000890600, ENST00000937634, ENST00000937635, ENST00000937636, ENST00000956223, ENST00000956224, ENST00000956225, ENST00000956226, ENST00000956227, ENST00000956228
RefSeq mRNA: 7 — MANE Select: NM_201453
NM_001291821, NM_001378113, NM_001378114, NM_001378115, NM_001378116, NM_001378117, NM_201453
CCDS: CCDS35038
Canonical transcript exons
ENST00000360171 — 15 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001694232 | 68247613 | 68247709 |
| ENSE00001919062 | 68241983 | 68242185 |
| ENSE00001931319 | 68299481 | 68300035 |
| ENSE00003299788 | 68248806 | 68248897 |
| ENSE00003461068 | 68297752 | 68297817 |
| ENSE00003482697 | 68256921 | 68256980 |
| ENSE00003517114 | 68297580 | 68297648 |
| ENSE00003521900 | 68268934 | 68268978 |
| ENSE00003562988 | 68245213 | 68245299 |
| ENSE00003626055 | 68258532 | 68258569 |
| ENSE00003630427 | 68274882 | 68274938 |
| ENSE00003630488 | 68298964 | 68299093 |
| ENSE00003633718 | 68264468 | 68264514 |
| ENSE00003635966 | 68266220 | 68266306 |
| ENSE00003657818 | 68285989 | 68286040 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 93.22.
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| monocyte | CL:0000576 | 93.22 | gold quality |
| calcaneal tendon | UBERON:0003701 | 93.22 | gold quality |
| leukocyte | CL:0000738 | 92.47 | gold quality |
| islet of Langerhans | UBERON:0000006 | 91.71 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 91.49 | gold quality |
| sural nerve | UBERON:0015488 | 91.06 | gold quality |
| vermiform appendix | UBERON:0001154 | 89.92 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 89.87 | gold quality |
| pancreas | UBERON:0001264 | 89.75 | gold quality |
| cerebellar cortex | UBERON:0002129 | 89.67 | gold quality |
| cerebellum | UBERON:0002037 | 89.66 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 89.65 | gold quality |
| tonsil | UBERON:0002372 | 89.50 | gold quality |
| adenohypophysis | UBERON:0002196 | 89.42 | gold quality |
| liver | UBERON:0002107 | 89.41 | gold quality |
| body of pancreas | UBERON:0001150 | 89.19 | gold quality |
| pituitary gland | UBERON:0000007 | 88.96 | gold quality |
| right adrenal gland | UBERON:0001233 | 88.90 | gold quality |
| nucleus accumbens | UBERON:0001882 | 88.71 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 88.61 | gold quality |
| granulocyte | CL:0000094 | 88.59 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 88.49 | gold quality |
| left adrenal gland | UBERON:0001234 | 88.41 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 88.29 | gold quality |
| hypothalamus | UBERON:0001898 | 88.24 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 88.04 | gold quality |
| Ammon’s horn | UBERON:0001954 | 88.03 | gold quality |
| adrenal gland | UBERON:0002369 | 87.99 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 87.96 | gold quality |
| right frontal lobe | UBERON:0002810 | 87.92 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 20.82 |
| E-ENAD-20 | no | 62.02 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
53 targeting ZNG1C, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AQ-5P | 99.94 | 71.34 | 3426 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
| HSA-MIR-548AU-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AY-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548B-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548BB-5P | 99.94 | 71.27 | 3509 |
| HSA-MIR-548C-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548D-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548H-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548I | 99.94 | 71.25 | 3481 |
| HSA-MIR-548J-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548O-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548W | 99.94 | 71.24 | 3488 |
| HSA-MIR-548Y | 99.94 | 71.28 | 3514 |
| HSA-MIR-101-3P | 99.94 | 75.03 | 2230 |
| HSA-MIR-380-3P | 99.89 | 70.18 | 1978 |
| HSA-MIR-221-3P | 99.86 | 71.56 | 1329 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | cbwd | ENSDARG00000004318 |
| mus_musculus | Zng1 | ENSMUSG00000024878 |
| rattus_norvegicus | Zng1a | ENSRNOG00000015516 |
Paralogs (4): ZNG1B (ENSG00000136682), ZNG1E (ENSG00000147996), ZNG1A (ENSG00000172785), ZNG1F (ENSG00000215126)
Protein
Protein identifiers
Zinc-regulated GTPase metalloprotein activator 1C — Q5JTY5 (reviewed: Q5JTY5)
Alternative names: Cobalamin synthase W domain-containing protein 3
All UniProt accessions (8): A0A087WWG3, A0A087WYD2, A0A0A0MRU4, A0A0B4J2E3, Q5JTY5, F2Z3P0, Q5JTY2, Q5RIB5
UniProt curated annotations — full annotation on UniProt →
Function. Zinc chaperone that directly transfers zinc cofactor to target metalloproteins, thereby activating them. Catalyzes zinc insertion into the active site of methionine aminopeptidase METAP1, which function to cleave the initiator methionine from polypeptides during or after protein translation. Mechanistically, the N-terminal psi-PxLVp motif binds to the C6H2-type zinc finger of inactive form of METAP1. After formation of the docked complex, zinc is transferred from the CXCC motif in the GTPase domain of ZNG1C to the zinc binding site in the peptidase domain of METAP1 in a process requiring GTP hydrolysis. GTP/GDP exchange is required for release of active METAP1.
Subcellular location. Nucleus.
Similarity. Belongs to the SIMIBI class G3E GTPase family. ZNG1 subfamily.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5JTY5-1 | 1 | yes |
| Q5JTY5-2 | 2 |
RefSeq proteins (7): NP_001278750, NP_001365042, NP_001365043, NP_001365044, NP_001365045, NP_001365046, NP_958861* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003495 | CobW/HypB/UreG_nucleotide-bd | Domain |
| IPR011629 | CobW-like_C | Domain |
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
| IPR036627 | CobW-likC_sf | Homologous_superfamily |
| IPR051316 | Zinc-reg_GTPase_activator | Family |
Pfam: PF02492, PF07683
Catalyzed reactions (Rhea), 1 shown:
- GTP + H2O = GDP + phosphate + H(+) (RHEA:19669)
UniProt features (14 total): binding site 6, short sequence motif 2, chain 1, domain 1, splice variant 1, sequence conflict 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5JTY5-F1 | 75.73 | 0.36 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (6): 110; 203–206; 49–56; 107; 109; 110–114
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 36 (showing top):
GOBP_PROTEIN_MATURATION, SANSOM_APC_TARGETS, chr9q21, GOMF_METALLOCHAPERONE_ACTIVITY, GOMF_MOLECULAR_CARRIER_ACTIVITY, MIR559, MIR548Y, MIR548BB_5P, MIR548AR_5P, MIR548AD_5P_MIR548AE_5P_MIR548AY_5P_MIR548B_5P_MIR548D_5P, MIR548AK_MIR548AM_5P_MIR548C_5P_MIR548H_5P_MIR548O_5P_MIR548AU_5P, MIR548O_5P_MIR548W, MIR548AB, MIR548AS_5P, MIR548A_5P
GO Biological Process (0):
GO Molecular Function (5): GTP binding (GO:0005525), hydrolase activity (GO:0016787), metal ion binding (GO:0046872), nucleotide binding (GO:0000166), protein binding (GO:0005515)
GO Cellular Component (2): nucleus (GO:0005634), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| guanyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| catalytic activity | 1 |
| cation binding | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
366 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNG1C | SETD2 | Q9BYW2 | 549 |
| ZNG1C | ANKRD20A3P | Q5VUR7 | 544 |
| ZNG1C | FAM72C | H0Y354 | 490 |
| ZNG1C | FAM72B | Q86X60 | 484 |
| ZNG1C | ANKRD20A2P | Q5SQ80 | 478 |
| ZNG1C | ANKRD20A4P | Q4UJ75 | 477 |
| ZNG1C | TRIM49C | P0CI26 | 471 |
| ZNG1C | HSPB3 | Q12988 | 469 |
| ZNG1C | FAM72D | Q6L9T8 | 449 |
| ZNG1C | ANKRD20A1 | Q5TYW2 | 435 |
| ZNG1C | FAM72A | Q5TYM5 | 426 |
| ZNG1C | DHRS4L2 | Q6PKH6 | 399 |
| ZNG1C | B8ZZ87 | B8ZZ87 | 378 |
| ZNG1C | POTEJ | P0CG39 | 371 |
| ZNG1C | TBC1D19 | Q8N5T2 | 370 |
IntAct
144 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DNAJB11 | HSPA5 | psi-mi:“MI:0914”(association) | 0.830 |
| ARPC5 | ARPC3 | psi-mi:“MI:0914”(association) | 0.730 |
| FAM9C | NDC80 | psi-mi:“MI:0914”(association) | 0.670 |
| ZNG1C | ZMYND19 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNG1C | APBB2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CASP6 | ZNG1C | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNG1C | DNM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNG1C | TOR1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNG1C | psi-mi:“MI:0915”(physical association) | 0.560 | |
| ZNG1C | HIP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LAMP2 | ZNG1C | psi-mi:“MI:0915”(physical association) | 0.560 |
| RAN | ZNG1C | psi-mi:“MI:0915”(physical association) | 0.560 |
| PEX26 | ZNG1C | psi-mi:“MI:0915”(physical association) | 0.560 |
| HTT | ZNG1C | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (133): CBWD3 (Affinity Capture-MS), CBWD3 (Affinity Capture-MS), CBWD3 (Affinity Capture-MS), CBWD3 (Affinity Capture-MS), CBWD3 (Affinity Capture-MS), CBWD3 (Affinity Capture-MS), CBWD3 (Affinity Capture-MS), CBWD3 (Affinity Capture-MS), CBWD3 (Affinity Capture-MS), CBWD3 (Affinity Capture-MS), CBWD3 (Affinity Capture-MS), CBWD3 (Affinity Capture-MS), CBWD3 (Affinity Capture-MS), CBWD3 (Affinity Capture-MS), CBWD3 (Affinity Capture-MS)
ESM2 similar proteins: A0A078BQP2, A0A131MCZ8, A0JN54, A3KGB4, A3QM97, A8WPG9, G5ED05, O16715, O88673, P11528, P20192, P23743, P23897, P25092, P30733, P33530, P49619, P49620, P49621, P51556, P55141, P55204, P70106, P90895, P91550, Q03603, Q09435, Q0IIM8, Q10029, Q17586, Q19954, Q22949, Q23681, Q3UWA6, Q4V339, Q4V3C7, Q5JTY5, Q5RIA9, Q618H8, Q67XQ0
Diamond homologs: B0R0B1, O74310, P24203, P31521, P33030, P53729, P94400, Q4V339, Q5JTY5, Q5RIA9, Q8IUF1, Q8VEH6, Q99MB4, Q9BRT8, P22042, P29937, Q869Q0, Q9HZQ2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
38 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 30 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2981 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:68245207:TTATA:T | acceptor_loss | 1.0000 |
| 9:68245208:TATAG:T | acceptor_loss | 1.0000 |
| 9:68245209:ATAGG:A | acceptor_loss | 1.0000 |
| 9:68245210:TA:T | acceptor_loss | 1.0000 |
| 9:68245211:AGGTG:A | acceptor_loss | 1.0000 |
| 9:68245212:G:T | acceptor_loss | 1.0000 |
| 9:68245295:GGAAG:G | donor_gain | 1.0000 |
| 9:68245296:GAAG:G | donor_gain | 1.0000 |
| 9:68245296:GAAGG:G | donor_gain | 1.0000 |
| 9:68245300:G:GG | donor_gain | 1.0000 |
| 9:68245300:GT:G | donor_loss | 1.0000 |
| 9:68245301:T:G | donor_loss | 1.0000 |
| 9:68247705:GTGAA:G | donor_gain | 1.0000 |
| 9:68247707:G:GT | donor_gain | 1.0000 |
| 9:68247707:GAA:G | donor_gain | 1.0000 |
| 9:68247710:G:GG | donor_gain | 1.0000 |
| 9:68247715:G:GT | donor_gain | 1.0000 |
| 9:68247716:A:T | donor_gain | 1.0000 |
| 9:68248897:GG:G | donor_loss | 1.0000 |
| 9:68258526:TTGTA:T | acceptor_loss | 1.0000 |
| 9:68258527:TGTA:T | acceptor_loss | 1.0000 |
| 9:68258528:GTAG:G | acceptor_loss | 1.0000 |
| 9:68258529:TAG:T | acceptor_loss | 1.0000 |
| 9:68258530:A:AG | acceptor_gain | 1.0000 |
| 9:68258530:A:T | acceptor_loss | 1.0000 |
| 9:68258531:G:GA | acceptor_loss | 1.0000 |
| 9:68258531:G:GG | acceptor_gain | 1.0000 |
| 9:68258570:G:GG | donor_gain | 1.0000 |
| 9:68261002:G:GG | donor_gain | 1.0000 |
| 9:68266219:GGCAA:G | acceptor_gain | 1.0000 |
AlphaMissense
2597 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:68299481:G:A | G361D | 0.995 |
| 9:68299093:G:C | G361R | 0.991 |
| 9:68299481:G:T | G361V | 0.990 |
| 9:68299088:T:C | L359P | 0.988 |
| 9:68299004:T:A | V331D | 0.982 |
| 9:68297590:C:T | T276I | 0.981 |
| 9:68297813:T:C | L316P | 0.981 |
| 9:68299505:T:C | L369P | 0.981 |
| 9:68266255:A:T | K204I | 0.979 |
| 9:68297756:T:C | L297P | 0.977 |
| 9:68297817:G:C | K317N | 0.976 |
| 9:68297817:G:T | K317N | 0.976 |
| 9:68299490:T:C | L364S | 0.976 |
| 9:68299093:G:T | G361C | 0.974 |
| 9:68297590:C:A | T276K | 0.972 |
| 9:68298964:G:A | G318R | 0.971 |
| 9:68298964:G:C | G318R | 0.971 |
| 9:68299088:T:G | L359R | 0.966 |
| 9:68274916:T:C | F248L | 0.964 |
| 9:68274918:T:A | F248L | 0.964 |
| 9:68274918:T:G | F248L | 0.964 |
| 9:68297810:G:C | R315T | 0.963 |
| 9:68299009:G:C | G333R | 0.962 |
| 9:68299505:T:A | L369H | 0.961 |
| 9:68298965:G:A | G318E | 0.959 |
| 9:68297590:C:G | T276R | 0.958 |
| 9:68299010:G:A | G333D | 0.956 |
| 9:68297811:G:C | R315S | 0.954 |
| 9:68297811:G:T | R315S | 0.954 |
| 9:68297632:T:C | L290P | 0.953 |
dbSNP variants (sampled 300 via entrez): RS10083632 (9:68277578 C>G), RS10114848 (9:68276781 G>A,C,T), RS10115438 (9:68250261 A>T), RS10115441 (9:68250290 A>G), RS10117536 (9:68250374 G>A), RS10117571 (9:68250531 G>A), RS10121742 (9:68277420 C>A,T), RS10124324 (9:68277839 T>C), RS10124919 (9:68276831 A>G,T), RS10125095 (9:68277379 A>C,G), RS10125718 (9:68277570 A>G), RS10125892 (9:68280766 G>A), RS1025464039 (9:68278092 G>A), RS10429494 (9:68296015 C>T), RS1043609 (9:68299025 A>G)
Disease associations
OMIM: gene MIM:611080 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | affects cotreatment, increases abundance, increases expression | 2 |
| alpha-pinene | affects cotreatment, increases expression, increases abundance | 1 |
| methacrylaldehyde | affects cotreatment, increases expression, increases abundance | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | increases expression | 1 |
| Resveratrol | increases expression, affects cotreatment | 1 |
| Acrolein | affects cotreatment, increases expression, increases abundance | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Diethylhexyl Phthalate | increases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Ozone | affects cotreatment, increases expression, increases abundance | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Testosterone | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
| Volatile Organic Compounds | affects cotreatment, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.